CompanyDrug

Fudan-Zhangjiang’s JAK1 Inhibitor FZJ-003 Gel Enters Phase I Trial for Atopic Dermatitis

CompanyDrug

HutchMed’s Elunate Shows Survival Benefit in Global CRC Study at ESMO

CompanyDrug

Jacobio’s KRAS G12C Inhibitor JAB-21822 Advances to Pivotal Phase II in NSCLC

CompanyDeals

Lianren Digital Health Partners with Ningbo Government on Health Data Ecosystem

CompanyDeals

Bio-Heart Invests RMB 50M in Cardiotek to Advance Balloon-Expandable TAVR Device

CompanyDeals

HitGen’s Vernalis Subsidiary Collaborates with Unison Medicines on Undruggable Bacterial Target

CompanyDrug

Clover Biopharmaceuticals’ COVID-19 Vaccine SCB-2019 Shows Superior Booster Efficacy in Phase III Trial

CompanyDrug

Astellas’ Fezolinetant Hits Menopause Trial Goals in China, Eyes Global Launch

CompanyDeals

CellOrigin and Qilu Partner on Global CAR-iMAC Cancer Therapy Development

CompanyDeals

Bio-Heart Plans STAR Board IPO After Hong Kong Debut to Advance Cardiovascular Therapies

CompanyDeals

Fosun Pharma’s Controlling Shareholder to Sell 3% Stake for USD 461 Million

CompanyDrug

SciClone Pharmaceuticals Doses First Patient in RRx-001 Phase III Study for SCLC